{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":27,"n_cols":5,"rows_kept":27,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[13,2,13,3],[14,2,14,3],[15,2,15,3],[19,2,19,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910830817203321"]
[null,null,"Autore",null,"Brown D. J"]
[null,null,"Titolo",null,"Quinoxalines . Supplement II [[electronic resource] /] / D.J. Brown"]
[null,null,"Pubbl/distr/stampa",null,"Hoboken, N.J., : Wiley, c2004"]
[null,null,"ISBN",null,"1-280-36786-5"]
[{"$nulls":4},"9786610367863"]
[{"$nulls":4},"0-470-30766-8"]
[{"$nulls":4},"0-471-53340-8"]
[{"$nulls":4},"0-471-53377-7"]
[null,null,"Descrizione fisica",null,"1 online resource (528 p.)"]
[null,null,"Collana",null,"The chemistry of heterocyclic compounds ; ; v. 61"]
[null,null,"Disciplina",null,"547.593"]
[{"$nulls":4},"547/.59/05"]
[null,null,"Soggetti",null,"Quinoxalines"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Interscience publication.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 437-470) and index."]
[null,null,"Nota di contenuto",null,"QUINOXALINES Supplement II; Preface; Contents; CHAPTER 1 PRIMARY SYNTHESES; 1.1 From a Single Benzene Substrate; 1.1.1 By Formation of the N1,C8a Bond; 1.1.2 By Formation of the N1,C2 Bond; 1.1.2.1 Cyclization of o-(Ethylamino)aniline Derivatives; 1.1.2.2 Direct Cyclization of o-(Ethylamino)nitrobenzene Derivatives; 1.1.2.3 Reductive Cyclization of o-(Ethylamino)nitrobenzene Derivatives; 1.1.3 By Formation of the C2,C3 Bond; 1.2 From a Benzene Substrate with an Ancillary Synthon; 1.2.1 When the Synthon Supplies N1 of the Quinoxaline; 1.2.2 When the Synthon Supplies C2 of the Quinoxaline"]
[{"$nulls":4},"1.2.3 When the Synthon Supplies C2 + C3 of the Quinoxaline1.2.3.1 Using a Dialdehyde (Glyoxal) or Related Synthon; 1.2.3.2 Using an Aldehydo Ketone or Related Synthon; 1.2.3.3 Using an Aldehydo Acid or Related Synthon; 1.2.3.4 Using an Aldehydo Ester or Related Synthon; 1.2.3.5 Using an Aldehydo Amide, Nitrile, Acyl Halide, or Related Synthon; 1.2.3.6 Using a Diketone or Related Synthon; 1.2.3.7 Using a Keto Acid or Related Synthon; 1.2.3.8 Using a Keto Ester or Related Synthon; 1.2.3.9 Using a Keto Amide, Nitrile, Acyl Halide, or Related Synthon"]
[{"$nulls":4},"1.2.3.10 Using a Diacid (Oxalic Acid) as Synthon1.2.3.11 Using a Diester (a Dialkyl Oxalate) or Related Synthon; 1.2.3.12 Using an Estero Amide, Nitrile, Acyl Halide, or Related Synthon; 1.2.3.13 Using a Diamide (Oxamide), Amido Nitrile, or Related Synthon; 1.2.3.14 Using a "]
[{"$nulls":4},"Diacyl Dihalide (Oxalyl Halide) or Related Synthon; 1.2.4 When the Synthon Supplies N1 + C2 + C3 of the Quinoxaline; 1.2.5 When the Synthon Supplies N1 + C2 + C3 + N4 of the Quinoxaline; 1.3 From a Benzene Substrate with Two or More Synthons; 1.4 From a Pyrazine Substrate with or without Synthon(s)"]
[{"$nulls":4},"1.5 From Other Heteromonocyclic Substrates/Synthons1.5.1 Azirines as Substrates/Synthons; 1.5.2 1,2,3-Dithiazol-1-iums as Substrates/Synthons; 1.5.3 Furans as Substrates/Synthons; 1.5.4 Isothiazoles as Substrates/Synthons; 1.5.5 Isoxazoles as Substrates/Synthons; 1.5.6 Oxazoles as Substrates/Synthons; 1.5.7 Oxirenes as Substrates/Synthons; 1.5.8 Pyrans as Substrates/Synthons; 1.5.9 Pyridazines as Substrates/Synthons; 1.5.10 Pyridines as Substrates/Synthons; 1.5.11 Pyrimidines as Substrates/Synthons; 1.5.12 Pyrroles as Substrates/Synthons; 1.5.13 Thiophenes as Substrates/Synthons"]
[{"$nulls":4},"1.5.14 1,2,4-Triazines as Substrates/Synthons1.5.15 1,2,3-Triazoles as Substrates/Synthons; 1.6 From Heterobicyclic Substrates/Synthons; 1.6.1 7-Azabicyclo[4.1.0]heptanes as Substrates/Synthons; 1.6.2 Benzimidazoles as Substrates/Synthons; 1.6.3 1,4-Benzodiazepines as Substrates/Synthons; 1.6.4 1,5-Benzodiazepines as Substrates/Synthons; 1.6.5 1-Benzopyrans (Chromenes) as Substrates/Synthons; 1.6.6 2,1,3-Benzoselena(or thia)diazoles as Substrates/Synthons; 1.6.7 2,1,3-Benzoxadiazoles as Substrates/Synthons; 1.6.8 Cycloheptapyrazines as Substrates/Synthons; 1.6.9 Indoles as Substrates/Synthons"]
[{"$nulls":4},"1.6.10 Pyrrolo[3,4-b]pyrazines as Substrates/Synthons"]
[null,null,null,"Sommario/riassunto","This volume in the Chemistry of Heterocyclic Compounds series presents a comprehensive review of the quinoxaline literature from 1975 to the present (2002), updating Volumes 5 and 35. It provides an alphabetical table of known simple quinoxalines, including new compounds discussed in this volume and their physical data, as well as the pyrazines from the original volumes. Biological activities, spectral or other physical studies, and other such materials appear at appropriate points in the text. The in-depth coverage includes synthesis, reactions, spectroscopic, and physical properties for each"]